CD33 and leukemia: Figure 7G showed decreased WBC count in the peripheral blood of mice treated with miR‐125b ASO‐loaded CD33‐targeting RBCEVs compared to the control groups, indicating lesser circulating human leukaemia cells in mouse blood.